Loss of heterozygosity in BRCA1 and BRCA2 markers and high‐grade malignancy in breast cancer
- 1 January 1999
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 53 (1) , 9-17
- https://doi.org/10.1023/a:1006082117266
Abstract
Loss of heterozygosity (LOH) in loci of the 17q21 and 13q12‐13 regions can collaborate in the inactivation of BRCA1, BRCA2, and possibly other genes implicated in the pathogenesis of breast...Keywords
This publication has 25 references indexed in Scilit:
- Loss of Heterozygosity in Normal Tissue Adjacent to Breast CarcinomasScience, 1996
- Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomasThe Lancet, 1996
- Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancerBritish Journal of Cancer, 1996
- Inherited breast and ovarian cancerHuman Molecular Genetics, 1995
- High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: Correlation with high pgr and low s phaseInternational Journal of Cancer, 1995
- (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.Proceedings of the National Academy of Sciences, 1994
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Tumor Suppressor GenesScience, 1991
- Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.Proceedings of the National Academy of Sciences, 1991
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990